{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:35:57Z","timestamp":1788287757045,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2019ER690101"],"award-info":[{"award-number":["2019ER690101"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF- 2019R1C1C1003077"],"award-info":[{"award-number":["NRF- 2019R1C1C1003077"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.trsl.2020.10.007","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T10:51:55Z","timestamp":1603536715000},"page":"34-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["CD71 mesangial IgA1 receptor and the progression of IgA nephropathy"],"prefix":"10.1016","volume":"230","author":[{"given":"Jong Hyun","family":"Jhee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Young","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Tak","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Ik","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ea Wha","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Jin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hyun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Joo","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyeok","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2020.10.007_bib0001","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.10.007_bib0002","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMra020109","article-title":"IgA nephropathy","volume":"347","author":"Donadio","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.10.007_bib0003","doi-asserted-by":"crossref","first-page":"60","DOI":"10.23876\/j.krcp.19.077","article-title":"Patterns in renal diseases diagnosed by kidney biopsy: a single-center experience","volume":"39","author":"Yim","year":"2020","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.trsl.2020.10.007_bib0004","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/ndt\/17.1.64","article-title":"Prognostic indicators of IgA nephropathy in the Chinese\u2013clinical and pathological perspectives","volume":"17","author":"Li","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2020.10.007_bib0005","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1681\/ASN.V881324","article-title":"Immunoglobulin A nephropathy: a clinical perspective","volume":"8","author":"Donadio","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0006","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/joneph\/18.5.503","article-title":"Factors predicting progression of IgA nephropathies","volume":"18","author":"Coppo","year":"2005","journal-title":"J Nephrol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0007","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00281-013-0411-7","article-title":"New insights into the pathogenesis of IgA nephropathy","volume":"36","author":"Floege","year":"2014","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40620-015-0246-5","article-title":"Role of IgA receptors in the pathogenesis of IgA nephropathy","volume":"29","author":"Lechner","year":"2016","journal-title":"J Nephrol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0009","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.191.11.1999","article-title":"Fc alpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice","volume":"191","author":"Launay","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2020.10.007_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/labinvest.3700012","article-title":"Age-dependent decrease of polymeric Ig receptor expression and IgA elevation in ddY mice: a possible cause of IgA nephropathy","volume":"84","author":"Yanagihara","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.trsl.2020.10.007_bib0011","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1006\/bbrc.2001.6218","article-title":"Expression of Fc alpha\/mu receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy","volume":"290","author":"McDonald","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2020.10.007_bib0012","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1681\/ASN.V94568","article-title":"Mesangial cells possess an asialoglycoprotein receptor with affinity for human immunoglobulin A","volume":"9","author":"Gomez-Guerrero","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0013","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.kint.2017.05.002","article-title":"Beta1,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells","volume":"92","author":"Molyneux","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.10.007_bib0014","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.194.4.417","article-title":"Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy","volume":"194","author":"Moura","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2020.10.007_bib0015","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/nm.2462","article-title":"Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia","volume":"17","author":"Coulon","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2020.10.007_bib0016","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/01.ASN.0000046961.04917.83","article-title":"Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schonlein nephritis: association between CD71 expression and IgA deposits","volume":"14","author":"Haddad","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0017","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.trsl.2020.10.007_bib0018","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4049\/jimmunol.1302249","article-title":"The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy","volume":"193","author":"Schmitt","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0019","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/07853890.2016.1252058","article-title":"Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy","volume":"49","author":"Yoon","year":"2017","journal-title":"Ann Med"},{"key":"10.1016\/j.trsl.2020.10.007_bib0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00281-007-0089-9","article-title":"Immunopathogenesis of IgAN","volume":"29","author":"Barratt","year":"2007","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0021","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/sj.ki.5002185","article-title":"Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels","volume":"71","author":"Moldoveanu","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.10.007_bib0022","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1523-1755.2005.67107.x","article-title":"IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells","volume":"67","author":"Novak","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.10.007_bib0023","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.4049\/jimmunol.153.11.5247","article-title":"Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation","volume":"153","author":"Gomez-Guerrero","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0024","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ki.2015.158","article-title":"Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes","volume":"88","author":"Berthelot","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.10.007_bib0025","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/ki.2010.314","article-title":"Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy","volume":"78","author":"Vuong","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.10.007_bib0026","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1523-1755.2003.00756.x","article-title":"Complexes of IgA with Fc alpha RI\/CD89 are not specific for primary IgA nephropathy","volume":"63","author":"van der Boog","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.10.007_bib0027","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/ki.2011.276","article-title":"Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases","volume":"80","author":"Tissandi\u00e9","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.10.007_bib0028","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1515\/cclm-2017-0090","article-title":"Circulating CD89-IgA complex does not predict deterioration of kidney function in Korean patients with IgA nephropathy","volume":"56","author":"Jhee","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.trsl.2020.10.007_bib0029","first-page":"1668","article-title":"Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity","volume":"119","author":"Suzuki","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2020.10.007_bib0030","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1681\/ASN.2012010053","article-title":"Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy","volume":"23","author":"Berthoux","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0031","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000382134","article-title":"New Insights into the Pathogenesis of IgA Nephropathy","volume":"1","author":"Novak","year":"2015","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.trsl.2020.10.007_bib0032","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","article-title":"IgA nephropathy","volume":"2","author":"Lai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.trsl.2020.10.007_bib0033","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1681\/ASN.2004111006","article-title":"Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy","volume":"16","author":"Moura","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0034","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ki.2012.192","article-title":"The IgA1 immune complex-mediated activation of the MAPK\/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy","volume":"82","author":"Tamouza","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.10.007_bib0035","first-page":"385","article-title":"Expression of three cell proliferation-associated antigens, DNA polymerase alpha, Ki-67 antigen and transferrin receptor in nodal and cutaneous T-cell lymphomas","volume":"54","author":"Mitani","year":"1991","journal-title":"Int J Hematol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0036","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ki.2011.126","article-title":"Validation of the Oxford classification of IgA nephropathy","volume":"80","author":"Herzenberg","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.10.007_bib0037","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.2215\/CJN.02890311","article-title":"Validation study of Oxford classification of IgA nephropathy: the significance of extracapillary proliferation","volume":"6","author":"Katafuchi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0038","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.2015.322","article-title":"The MEST score provides earlier risk prediction in lgA nephropathy","volume":"89","author":"Barbour","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.10.007_bib0039","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.ajkd.2013.04.021","article-title":"Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis","volume":"62","author":"Lv","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trsl.2020.10.007_bib0040","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.2215\/CJN.11521210","article-title":"Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification","volume":"6","author":"Shi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0041","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2020.10.007_bib0042","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.ajkd.2012.02.326","article-title":"Risk stratification of patients with IgA nephropathy","volume":"59","author":"Barbour","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trsl.2020.10.007_bib0043","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/ndt\/gfg207","article-title":"A tricontinental view of IgA nephropathy","volume":"18","author":"Geddes","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2020.10.007_bib0044","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ki.2013.210","article-title":"Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease","volume":"84","author":"Barbour","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.10.007_bib0045","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/01.ASN.0000115401.07980.0C","article-title":"Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy","volume":"15","author":"Moura","year":"2004","journal-title":"J Am Soc Nephrol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420302486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420302486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:14:19Z","timestamp":1778832859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524420302486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":45,"alternative-id":["S1931524420302486"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2020.10.007","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD71 mesangial IgA1 receptor and the progression of IgA nephropathy","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2020.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}